Search research articles
Contact Us
Filters
Showing results (541-550 of 1,032) with videos related to
Page
of 104
Sort By:
Forensic Science International
|
April 22, 2014
Codeine-related deaths: The role of pharmacogenetics and drug interactions
Jessica Lam, Karen L Woodall, Patricia Solbeck, et al.
Biochemical and Biophysical Research Communications
|
February 8, 2006
Hemorheological abnormalities in lipoprotein lipase deficient mice with severe hypertriglyceridemia
Tieqiang Zhao, Jun Guo, Hui Li, et al.
Human Molecular Genetics
|
January 22, 2010
Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis
Kristina Becanovic, Mahmoud A Pouladi, Raymond S Lim, et al.
Neuroscience
|
April 2, 2016
Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin
C Connolly, A Magnusson-Lind, G Lu, et al.
American Journal of Human Genetics
|
October 23, 1997
Risk reversals in predictive testing for Huntington disease
E Almqvist, S Adam, M Bloch, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
August 6, 1999
Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin
A S Hackam, J G Hodgson, R Singaraja, et al.
The American Journal of Psychiatry
|
December 1, 2000
Familial aggregation of psychotic symptoms in Huntington's disease
D Tsuang, E W Almqvist, H Lipe, et al.
Plos One
|
October 8, 2011
Amelioration of hypertriglyceridemia with hypo-alpha-cholesterolemia in LPL deficient mice by hematopoietic cell-derived LPL
Yinyuan Ding, Ling Zhang, Yuhui Wang, et al.
The New England Journal of Medicine
|
November 12, 1992
The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing
S Wiggins, P Whyte, M Huggins, et al.
Peptides
|
November 4, 2009
The metabolic phenotype of SCD1-deficient mice is independent of melanin-concentrating hormone
Melissa B Glier, Pavlos Pissios, Sandra L Babich, et al.
Page
of 104
Search research articles
Search
Showing results (541-550 of 1,032) with videos related to
Sort By:
Page
of 104
Forensic Science International
|
April 22, 2014
Codeine-related deaths: The role of pharmacogenetics and drug interactions
Jessica Lam, Karen L Woodall, Patricia Solbeck, et al.
Biochemical and Biophysical Research Communications
|
February 8, 2006
Hemorheological abnormalities in lipoprotein lipase deficient mice with severe hypertriglyceridemia
Tieqiang Zhao, Jun Guo, Hui Li, et al.
Human Molecular Genetics
|
January 22, 2010
Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis
Kristina Becanovic, Mahmoud A Pouladi, Raymond S Lim, et al.
Neuroscience
|
April 2, 2016
Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin
C Connolly, A Magnusson-Lind, G Lu, et al.
American Journal of Human Genetics
|
October 23, 1997
Risk reversals in predictive testing for Huntington disease
E Almqvist, S Adam, M Bloch, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
August 6, 1999
Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin
A S Hackam, J G Hodgson, R Singaraja, et al.
The American Journal of Psychiatry
|
December 1, 2000
Familial aggregation of psychotic symptoms in Huntington's disease
D Tsuang, E W Almqvist, H Lipe, et al.
Plos One
|
October 8, 2011
Amelioration of hypertriglyceridemia with hypo-alpha-cholesterolemia in LPL deficient mice by hematopoietic cell-derived LPL
Yinyuan Ding, Ling Zhang, Yuhui Wang, et al.
The New England Journal of Medicine
|
November 12, 1992
The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing
S Wiggins, P Whyte, M Huggins, et al.
Peptides
|
November 4, 2009
The metabolic phenotype of SCD1-deficient mice is independent of melanin-concentrating hormone
Melissa B Glier, Pavlos Pissios, Sandra L Babich, et al.
Page
of 104